Rhenium SCT® is a non invasive one-time treatment
Rhenium‑SCT® is a non‑invasive one-time treatment that uses a radiotherapeutic paste to treat superficial (<3mm deep) non‑melanoma skin cancers, including:
- Basal cell carcinoma (BCC)
- Squamous cell carcinoma (SCC)
It provides an effective option for lesions where surgery or external beam radiotherapy can be difficult or undesirable.
How does Rhenium SCT® work?
It delivers localised beta radiation to the lesion in the form of a radioactive paste.
The radiation is delivered locally with minimal impact on surrounding healthy tissue, making it especially suitable for delicate areas like the face and hands.
The radiation penetrates only a few millimetres into the skin and precisely targets cancer cells.
How long does the treatment take?
Treatment is completed in a single session, typically lasting between 30 and 180 minutes . For most patients, one treatment is all that’s needed.
Lesion demarkated
Lesion covered with a plastic film and radioactive paste applied
Plastic film and radioactive paste removed
Are there any side effects to Rhenium SCT®?
The treatment is not painful and is well tolerated with minimal side effects. As the treated area reacts to the radiation applied it becomes red and forms moist and then dry scabbing as part of the healing process. The treated area often has a slightly lighter skin tone after healing has occurred. Healing typically occurs 30–90 days after treatment with Rhenium-SCT but may take longer depending on factors such as the size, depth, and location of the tumour and your general health.